OUR PRODUCTS

MOBILE APPS

GENERAL INFO

VRNA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Verona Pharma (VRNA) Earnings Date & Reports

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

VRNA is expected to report earnings to rise 22.71% to 17 cents per share on November 11

Verona Pharma VRNA Stock Earnings Reports

Q3'25

Est.

$0.17

Q2'25

Beat

by $0.11

Q1'25

Beat

by $0.05

Q4'24

Beat

by $0.02

Q3'24

Est.

$-0.07

The last earnings report on August 11 showed earnings per share of 14 cents, beating the estimate of 2 cents. With 560.28K shares outstanding, the current market capitalization sits at 9.07B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

VRNA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VRNA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRNA showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

3 More London Riverside

Phone

+44 2032834200

Employees

Web

https://www.veronapharma.com